REGION HOVEDSTADEN
Kongens Vaenge 2 – Hillerod – 3400
VAT: DK30113721
https://www.regionh.dk/
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, REGION HOVEDSTADEN has received € 3,087,704.0 for its participation in a total of 6 project(s) with a total cost of € 138,280,720.
| Start YYYYMMDD |
End YYYYMMDD |
Project ID | Project Name | Themes | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-01-01 | 2024-12-31 | 848011 | DC-ren | diabetic nephropathy · pharmaceutical drugs · pathophysiology · pathology · kidney diseases | participant | € 522,987.5 | € 5,968,480 | 1 | 8 | CORDIS ↪ |
| 2021-03-01 | 2025-02-28 | 955575 | T-OP | proteins · oncology · immunotherapy · cells technologies | participant | € 595,044.0 | € 4,100,958 | 1 | 12 | CORDIS ↪ |
| 2021-01-28 | 2024-01-27 | 101037867 | VACCELERATE | pandemics · coronaviruses · vaccines | participant | € 381,783.75 | € 26,499,804 | 1 | 32 | CORDIS ↪ |
| 2015-06-01 | 2018-05-31 | 634453 | EUthyroid | databases · obstetrics · halogens · endocrinology · ultrasound | participant | € 272,963.75 | € 3,375,330 | 1 | 31 | CORDIS ↪ |
| 2017-01-01 | 2022-06-30 | 733032 | HBM4EU | participant | € 1,307,425.62 | € 74,930,474 | 1 | 121 | CORDIS ↪ | |
| 2018-04-01 | 2023-03-31 | 777500 | IMI-PainCare | drug discovery · surgery · pharmaceutical drugs · pathophysiology · pharmacokinetics | participant | € 7,500.0 | € 23,405,673 | 1 | 41 | CORDIS ↪ |
Within the Horizon Europe (2021-2027) framework, REGION HOVEDSTADEN has received € 2,749,800.0 for its participation in a total of 8 project(s) with a total cost of € 592,351,635.
| Start YYYYMMDD |
End YYYYMMDD |
Project ID | Project Name | Themes | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-01 | 2027-10-31 | 101080117 | BETTER4U | obesity | participant | € 218,000.0 | € 9,495,241 | 1 | 28 | CORDIS ↪ |
| 2024-01-01 | 2029-12-31 | 101137146 | STAGE | public services | participant | € 718,606.0 | € 17,760,515 | 1 | 22 | CORDIS ↪ |
| 2022-05-01 | 2029-04-30 | 101057014 | PARC | public health · crisis management | thirdParty | € 0.0 | € 400,000,000 | 1 | 199 | CORDIS ↪ |
| 2023-01-01 | 2026-12-31 | 101095470 | miGut-Health | eHealth · nutrition · sensors | participant | € 338,625.0 | € 7,131,243 | 1 | 13 | CORDIS ↪ |
| 2023-04-01 | 2028-03-31 | 101104684 | PragmaTIL | oncology | participant | € 882,781.25 | € 5,998,839 | 1 | 13 | CORDIS ↪ |
| 2023-05-01 | 2028-04-30 | 101104582 | IntReALL 2020 | mortality · databases · leukemia | participant | € 215,000.0 | € 6,135,176 | 1 | 26 | CORDIS ↪ |
| 2024-09-01 | 2031-08-31 | 101156595 | ERDERA | ecosystems | participant | € 75,000.0 | € 145,830,619 | 2 | 178 | CORDIS ↪ |
| 2024-09-01 | 2028-08-31 | 101169473 | alignAI | participant | € 301,788.0 | € 0 | 2 | 13 | CORDIS ↪ |
Within the FP7 (2007-2013) framework, REGION HOVEDSTADEN has received € 4,248,366.0 for its participation in a total of 12 project(s) with a total cost of € 182,362,898.
| Start YYYYMMDD |
End YYYYMMDD |
Project ID | Project Name | Themes | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2009-03-01 | 2011-08-31 | 232447 | ICSC | drug discovery · philosophy | participant | € 3,200.0 | € 1,388,534 | 1 | 6 | CORDIS ↪ |
| 2013-01-01 | 2018-06-30 | 305340 | INFECT | participant | € 1,607,774.0 | € 15,680,322 | 1 | 16 | CORDIS ↪ | |
| 2009-01-01 | 2012-06-30 | 222995 | INFARCT CELL THERAPY | genetic engineering · tissue engineering · stem cells | participant | € 327,000.0 | € 3,567,100 | 2 | 9 | CORDIS ↪ |
| 2011-10-01 | 2017-09-30 | 278514 | INTREALL | drug discovery · mortality · databases · leukemia | participant | € 87,500.0 | € 7,763,823 | 1 | 29 | CORDIS ↪ |
| 2010-01-01 | 2015-06-30 | 241883 | BETACELLTHERAPY | diabetes · stem cells · transplantation · implants | participant | € 200,000.0 | € 15,919,619 | 1 | 18 | CORDIS ↪ |
| 2011-12-01 | 2017-05-31 | 278367 | EMTICS | obsessive-compulsive disorder | participant | € 135,016.0 | € 8,068,217 | 1 | 30 | CORDIS ↪ |
| 2012-03-01 | 2018-02-28 | 115303 | ABIRISK | rheumatology · databases · immunisation · multiple sclerosis · gastroenterology | participant | € 306,812.0 | € 32,851,056 | 2 | 38 | CORDIS ↪ |
| 2014-02-01 | 2020-01-31 | 603196 | PSYSCAN | psychiatry · machine learning | participant | € 52,399.98 | € 8,336,818 | 1 | 22 | CORDIS ↪ |
| 2012-01-01 | 2017-12-31 | 284395 | ECRIN-IA | nutrition | participant | € 400,781.74 | € 10,958,339 | 1 | 47 | CORDIS ↪ |
| 2012-11-01 | 2017-01-31 | 305061 | GAPVAC | proteomics · vaccines · oncology · personalized medicine · immunotherapy | participant | € 246,108.0 | € 7,918,396 | 1 | 13 | CORDIS ↪ |
| 2012-10-01 | 2018-03-31 | 115439 | STEMBANCC | neurobiology · drug discovery · diabetes · stem cells · toxicology | participant | € 167,771.0 | € 55,010,480 | 2 | 38 | CORDIS ↪ |
| 2010-02-01 | 2016-07-31 | 242114 | OPTIMISE | drug discovery · schizophrenia | participant | € 714,003.64 | € 14,900,190 | 1 | 23 | CORDIS ↪ |